Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Francic, V; Keppel, M; Schwetz, V; Trummer, C; Pandis, M; Borzan, V; Grübler, MR; Verheyen, ND; Kleber, ME; Delgado, G; Moissl, AP; Dieplinger, B; März, W; Tomaschitz, A; Pilz, S; Obermayer-Pietsch, B.
Are soluble ST2 levels influenced by vitamin D and/or the seasons?
ENDOCR CONNECT. 2019; 8(6): 691-700.
Doi: 10.1530/EC-19-0090
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Francic Vito
- Co-Autor*innen der Med Uni Graz
-
Borzan Valentin
-
Grübler Martin
-
Keppel Martin Helmut
-
März Winfried
-
Obermayer-Pietsch Barbara
-
Pandis Marlene
-
Pilz Stefan
-
Theiler-Schwetz Verena
-
Tomaschitz Andreas
-
Trummer Christian
-
Verheyen Nicolas Dominik
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: Cardiovascular disease manifestation and several associated surrogate markers, such as vitamin D, have shown substantial seasonal variation. A promising cardiovascular biomarker, soluble ST2 (sST2), has not been investigated in this regard – we therefore determined if systemic levels of sST2 are affected by seasonality and/or vitamin D in order to investigate their clinical interrelation and usability. DESIGN: sST2 levels were measured in two cohorts involving hypertensive patients at cardiovascular risk, the Styrian Vitamin D Hypertension Trial (study A; RCT design, 8 weeks 2800 IU cholecalciferol daily) and the Ludwigshafen Risk and Cardiovascular Health Study (LURIC; study B; cross-sectional design).
- Find related publications in this database (Keywords)
-
soluble ST2
-
seasonality
-
vitamin D
-
biomarker
-
cardiovascular disease